Literature DB >> 9422532

Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.

S P Wilczynski1, B T Lin, Y Xie, I B Paz.   

Abstract

Human papillomavirus (HPV) DNA has been detected in approximately 15% of squamous cell carcinomas (SCCs) of the head and neck. Recent studies have shown a predilection of HPV for certain anatomical sites, especially the tonsillar region, with viral DNA identified in approximately 60% of SCCs of the Waldeyer's tonsillar ring. This study was undertaken to determine whether there are differences in morphology or in oncogene expression in SCC of the tonsil with and without detectable HPV DNA. Twenty-two SCCs of the tonsil were analyzed for the presence of HPV DNA by polymerase chain reaction (PCR) using both a consensus primer set (My09/My11) and type-specific primers. Viral transcription was established in both primary and metastatic tumors by RNA in situ hybridization. The morphology of invasive SCC was classified into three subtypes: well keratinized (K-SCC), intermediate keratinized (I-SCC), and poorly keratinized (P-SCC). Expression of p53, pRB, and cyclin D1 (bcl-1) were studied by immunohistochemistry. In these cases (6 K-SCCs, 2 I-SCCs, and 14 P-SCCs), HPV DNA was detected in 14 (64%), with 11 containing HPV-16 (10 P-SCCs, 1 I-SCCs, and 0 K-SCCs) and 1 each containing HPV-33, HPV-59, and an unclassified HPV type (all P-SCCs). Viral oncoprotein E6/E7 transcription was demonstrated in 7 of 7 HPV-16-positive tumors. Cyclin D1 protein overexpression was detected in the majority of HPV-negative tumors (7 of 8 cases), whereas it was minimal or absent in 13 HPV-positive tumors. Overexpression of p53 protein was detected in 3 HPV-negative K-SCCs. In the HPV-positive tumors, fewer malignant cells expressed pRB and the staining was less intense than in the HPV-negative cancers. HPV DNA and E6/E7 expression, especially HPV-16, is detected in the majority of tonsillar SCCs and is almost exclusively associated with a poorly keratinized tumor histology. Decreased expression of cyclin D1, pRB, and p53 in tumors with HPV DNA is consistent with the known effects of the viral oncoproteins on the cellular protein. The morphology of the HPV-positive tumors suggests that HPV may have a predilection for a population of nonkeratinizing squamous cells or that the virally transformed cells inhibit keratinization of the tumor cells. Well keratinized tonsillar SCCs lack HPV DNA and are associated with overexpression of cyclin D1 protein and/or p53, suggesting that mechanisms that alter the cell cycle regulatory proteins, either by interaction with viral oncoproteins or by changes in the cellular proteins themselves, is critical for tumorigenesis of tonsillar SCC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422532      PMCID: PMC1858109     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Jarzabek-Chorzelska; S Obalek; G Rzesa; M Favre; O Croissant
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

2.  The human palatine tonsil studied from surgical specimens at all ages and in various pathological conditions. 1. Morphological and structural analyses.

Authors:  A Favre; D Paoli; M Poletti; A Marzoli; G Pesce; A Giampalmo; F Rossi
Journal:  Z Mikrosk Anat Forsch       Date:  1986

3.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

4.  Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy.

Authors:  S Y Chan; H Delius; A L Halpern; H U Bernard
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Physical interaction of the retinoblastoma protein with human D cyclins.

Authors:  S F Dowdy; P W Hinds; K Louie; S I Reed; A Arnold; R A Weinberg
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

6.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.

Authors:  J A Brennan; J O Boyle; W M Koch; S N Goodman; R H Hruban; Y J Eby; M J Couch; A A Forastiere; D Sidransky
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

7.  Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.

Authors:  Y Li; M A Nichols; J W Shay; Y Xiong
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

Review 8.  Biomarkers in upper aerodigestive tract tumorigenesis: a review.

Authors:  D M Shin; W N Hittelman; W K Hong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-12       Impact factor: 4.254

Review 9.  The D-type cyclins and their role in tumorigenesis.

Authors:  G Peters
Journal:  J Cell Sci Suppl       Date:  1994

10.  Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract.

Authors:  B J Monk; N Cook; C Ahn; S A Vasilev; M L Berman; S P Wilczynski
Journal:  Diagn Mol Pathol       Date:  1994-12
View more
  53 in total

Review 1.  Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.

Authors:  C Y Fan
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

2.  UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.

Authors:  Alice L Tang; Samantha J Hauff; John H Owen; Martin P Graham; Michael J Czerwinski; Jung Je Park; Heather Walline; Silvana Papagerakis; Jay Stoerker; Jonathan B McHugh; Douglas B Chepeha; Carol R Bradford; Thomas E Carey; Mark E Prince
Journal:  Head Neck       Date:  2011-12-13       Impact factor: 3.147

3.  HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.

Authors:  Katerina Strati; Paul F Lambert
Journal:  Expert Opin Med Diagn       Date:  2008-01-01

4.  Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection.

Authors:  Christina Kanaan; Diane Lorenzo; Maximilien Barret; Anne Audebourg; Sarah Leblanc; Stanislas Chaussade; Frédéric Prat; Benoît Terris
Journal:  Virchows Arch       Date:  2020-06-10       Impact factor: 4.064

Review 5.  Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination.

Authors:  Maura L Gillison
Journal:  J Adolesc Health       Date:  2008-10       Impact factor: 5.012

6.  In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines.

Authors:  Mei Zhang; Barbara Rose; C Soon Lee; Angela M Hong
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

7.  Multiparametric immune profiling in HPV- oral squamous cell cancer.

Authors:  Zipei Feng; Daniel Bethmann; Matthias Kappler; Carmen Ballesteros-Merino; Alexander Eckert; R Bryan Bell; Allen Cheng; Tuan Bui; Rom Leidner; Walter J Urba; Kent Johnson; Clifford Hoyt; Carlo B Bifulco; Juergen Bukur; Claudia Wickenhauser; Barbara Seliger; Bernard A Fox
Journal:  JCI Insight       Date:  2017-07-20

8.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.

Authors:  S Kondo; K Wakae; N Wakisaka; Y Nakanishi; K Ishikawa; T Komori; M Moriyama-Kita; K Endo; S Murono; Z Wang; K Kitamura; T Nishiyama; K Yamaguchi; S Shigenobu; M Muramatsu; T Yoshizaki
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

9.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Authors:  Solomon Jo; Agnes Juhasz; Keqiang Zhang; Christopher Ruel; Sofia Loera; Sharon P Wilczynski; Yun Yen; Xiyong Liu; Joshua Ellenhorn; Dean Lim; Benjamin Paz; George Somlo; Nayana Vora; Stephen Shibata
Journal:  Anticancer Res       Date:  2009-05       Impact factor: 2.480

10.  Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses.

Authors:  Tae Jeong Oh; Chang Jin Kim; Suk Kyung Woo; Tae Seung Kim; Dong Jun Jeong; Myung Soon Kim; Sunwoo Lee; Hyun Sill Cho; Sungwhan An
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.